This is a preprint.
Derivation of human trophoblast stem cells from placentas at birth
- PMID: 38746283
- PMCID: PMC11092656
- DOI: 10.1101/2024.05.01.592064
Derivation of human trophoblast stem cells from placentas at birth
Update in
-
Derivation of human trophoblast stem cells from placentas at birth.J Biol Chem. 2025 Jun;301(6):108505. doi: 10.1016/j.jbc.2025.108505. Epub 2025 Apr 10. J Biol Chem. 2025. PMID: 40221000 Free PMC article.
Abstract
Human trophoblast stem cells (hTSCs) have emerged as a powerful tool for modeling the placental cytotrophoblast (CTB) in vitro. hTSCs were originally derived from CTBs of the first trimester placenta or blastocyst-stage embryos in trophoblast stem cell medium (TSCM) that contains epidermal growth factor (EGF), the glycogen synthase kinase-beta (GSK3β) inhibitor CHIR99021, the transforming growth factor-beta (TGFβ) inhibitors A83-01 and SB431542, valproic acid (VPA), and the Rho-associated protein kinase (ROCK) inhibitor Y-27632. Here we show that hTSCs can be derived from CTBs isolated from the term placenta, using TSCM supplemented with a low concentration of mitochondrial pyruvate uptake inhibitor UK5099 and lipid-rich albumin (TUA medium). Notably, hTSCs could not be derived from term CTBs using TSCM alone, or in the absence of either UK5099 or lipid-rich albumin. Strikingly, hTSCs cultured in TUA medium for a few passages could be transitioned into TSCM and cultured thereafter in TSCM. hTSCs from term CTBs cultured in TUA medium as well as those transitioned into and cultured in TSCM thereafter could be differentiated to the extravillous trophoblast and syncytiotrophoblast lineages and exhibited high transcriptome similarity with hTSCs derived from first trimester CTBs. We anticipate that these results will enable facile derivation of hTSCs from normal and pathological placentas at birth with diverse genetic backgrounds and facilitate in vitro mechanistic studies in trophoblast biology.
Keywords: cytotrophoblast; extravillous trophoblast; human trophoblast stem cells; placenta; syncytiotrophoblast.
Conflict of interest statement
Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.
Figures
References
-
- James J. L. (2016) Stem Cells and Pregnancy Disorders: From Pathological Mechanisms to Therapeutic Horizons. Semin Reprod Med. 34, 17–26 - PubMed
-
- Goldman-Wohl D., and Yagel S. (2002) Regulation of trophoblast invasion: From normal implantation to pre-eclampsia. in Molecular and Cellular Endocrinology, pp. 233–238, 187, 233–238 - PubMed
-
- Chavatte-Palmer P., and Tarrade A. (2016) Placentation in different mammalian species. Annales d’Endocrinologie. 77, 67–74 - PubMed
-
- Okae H., Toh H., Sato T., Hiura H., Takahashi S., Shirane K., Kabayama Y., Suyama M., Sasaki H., and Arima T. (2018) Derivation of Human Trophoblast Stem Cells. Cell stem cell. 22, 50–63.e6 - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous